Excluding the impact of any potential asset sales, the Company expects
to generate an Underlying EBITDA of circa $10 million in 2H 15
With $75-$100M of businesses sold off it will dilute to somewhere closer to $3-$5M? ongoing presumably – so closer to $6-$10M FY
Sill undervalued, but the litigation hanging over keeping SP down
VET Price at posting:
16.0¢ Sentiment: Hold Disclosure: Held